Scrutinize the data and tweets to envisage if the closing price of $gild will swell or contract at 2017-03-09. Please affirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-23,-0.9,0.2,-1.4,0.8,0.8,0.2,-1.3,0.1,1.0,1.3,1.9
2017-02-24,-0.9,0.2,-1.3,0.8,0.8,-0.7,-1.5,-0.9,0.1,0.3,0.9
2017-02-27,-1.0,0.1,-1.0,0.8,0.8,-1.3,-1.7,-1.9,-0.8,-0.5,-0.1
2017-02-28,-0.2,0.7,-0.7,-0.0,-0.0,-0.9,-1.3,-2.1,-0.8,-0.5,-0.2
2017-03-01,0.9,1.1,-0.2,-0.4,-0.4,-0.1,-0.5,-1.9,-0.6,-0.1,0.2
2017-03-02,-0.8,0.5,-0.8,0.5,0.5,-0.3,-0.9,-2.1,-1.2,-0.6,-0.4
2017-03-03,-0.1,0.1,-0.7,0.3,0.3,-0.4,-1.1,-1.9,-1.6,-0.9,-0.7
2017-03-06,0.6,0.7,-0.6,-0.9,-0.9,0.4,-0.2,-0.6,-0.9,-0.1,0.1
2017-03-07,0.8,1.4,-0.3,-1.6,-1.6,1.6,1.4,1.1,0.4,1.3,1.6
2017-03-08,-1.0,0.4,-1.2,1.0,1.0,0.5,0.5,0.3,-0.8,0.2,0.6

2017-02-23: didn't momelitinib fail? i thought $gild stopped development, no? |rt AT_USER AT_USER a little bird told me $gild is concerned. and filled with lust.|AT_USER a little bird told me $gild is concerned. 
2017-02-24: connor bruggeman schooltrader made $300,000 and he is only 17!   $dis $alxn $noah $gild $qunr|leerink swann comments on gilead sciences, inc.¡¯s fy2021 earnings $gild  #acn|roll untested side of my $g
2017-02-25: rt AT_USER $gild |rt AT_USER wondering if $glpg or $gild will consider cgvhd for filgotinib one day (added to the list in the slide) |rt AT_USER $gild |$gild |i'm sick and tired of gilead sciences: pa
2017-02-27: 10-k $gild $ibb |$gild - statement of changes in beneficial ownership (4) |#biotechs scorching today, $ibb +3% --- i'm long $abbv $abt $bmy $gild $gsk $hqh $hql $lly $nvs $pfe $teva $thw $thq long-ter
2017-03-01: $gild weekly 70c buyer early, but couldn't get it into the gap. keep a eye on this one. |AT_USER AT_USER yes, but the pr they issued is to pump the price. $gild would never issue that.|scan results - 
2017-03-02: valeant: probably worthless, or risky but attractive now?  $abbv $abt $agn $endp $gild $myl $prgo $teva $vrx|rt AT_USER so $gild didnt buy anything with $xbi in the 40-50s .... waiting for lower pps .
2017-03-03: rt AT_USER $gild weekly. initial follow through higher from the inside-inside weeks $ibb |rt AT_USER tgif - yellen and the people's congress #fomc $tza $gild $spy $dia #futures --  |rt AT_USER tgif - 
2017-03-04: AT_USER $gild complain basically after other lower price entry, they can't easily reset list price w/o changing existing contracts.|gilead: oncology acquisition incoming  $glpg $incy $nvs $rhhby $gild
2017-03-05: rt AT_USER AT_USER i've seen $gild for $incy countless times but never $pfe for them. would complement xeljanz and other inflamm¡­|rt AT_USER $gild or $bmrn? |rt AT_USER $incy too big for $gild now, a
2017-03-06: 5 things for #pharma #marketers to know: mon., mar. 6 $gild #drugprices $googl #ai #cancer $sny $regn #fda $agn¡­ |AT_USER $gild keeps on delivering superb results from its pipeline. don't worry keep 
2017-03-07: rbc hints at potential m&amp;a for kite pharma $gild $kite $nvs  via AT_USER|$gild $gild |rt AT_USER fiercebiotech¡¯s 2016 rotten tomatoes:  $juno $nvs $arwr $gild $nwbo and more|trump tweets about a 
2017-03-08: AT_USER AT_USER AT_USER AT_USER what i in roi? $gild bought phrmset for $11b, but hep c drugs r&amp;d was just $500m.|$esrx fires back at $gild |rt AT_USER trending: in quick rebuttal, express scripts
Answer:
Scrutinize the data and tweets to envisage if the closing price of $gild will swell or contract at 2017-03-09. Please affirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-23,-0.9,0.2,-1.4,0.8,0.8,0.2,-1.3,0.1,1.0,1.3,1.9
2017-02-24,-0.9,0.2,-1.3,0.8,0.8,-0.7,-1.5,-0.9,0.1,0.3,0.9
2017-02-27,-1.0,0.1,-1.0,0.8,0.8,-1.3,-1.7,-1.9,-0.8,-0.5,-0.1
2017-02-28,-0.2,0.7,-0.7,-0.0,-0.0,-0.9,-1.3,-2.1,-0.8,-0.5,-0.2
2017-03-01,0.9,1.1,-0.2,-0.4,-0.4,-0.1,-0.5,-1.9,-0.6,-0.1,0.2
2017-03-02,-0.8,0.5,-0.8,0.5,0.5,-0.3,-0.9,-2.1,-1.2,-0.6,-0.4
2017-03-03,-0.1,0.1,-0.7,0.3,0.3,-0.4,-1.1,-1.9,-1.6,-0.9,-0.7
2017-03-06,0.6,0.7,-0.6,-0.9,-0.9,0.4,-0.2,-0.6,-0.9,-0.1,0.1
2017-03-07,0.8,1.4,-0.3,-1.6,-1.6,1.6,1.4,1.1,0.4,1.3,1.6
2017-03-08,-1.0,0.4,-1.2,1.0,1.0,0.5,0.5,0.3,-0.8,0.2,0.6

2017-02-23: didn't momelitinib fail? i thought $gild stopped development, no? |rt AT_USER AT_USER a little bird told me $gild is concerned. and filled with lust.|AT_USER a little bird told me $gild is concerned. 
2017-02-24: connor bruggeman schooltrader made $300,000 and he is only 17!   $dis $alxn $noah $gild $qunr|leerink swann comments on gilead sciences, inc.¡¯s fy2021 earnings $gild  #acn|roll untested side of my $g
2017-02-25: rt AT_USER $gild |rt AT_USER wondering if $glpg or $gild will consider cgvhd for filgotinib one day (added to the list in the slide) |rt AT_USER $gild |$gild |i'm sick and tired of gilead sciences: pa
2017-02-27: 10-k $gild $ibb |$gild - statement of changes in beneficial ownership (4) |#biotechs scorching today, $ibb +3% --- i'm long $abbv $abt $bmy $gild $gsk $hqh $hql $lly $nvs $pfe $teva $thw $thq long-ter
2017-03-01: $gild weekly 70c buyer early, but couldn't get it into the gap. keep a eye on this one. |AT_USER AT_USER yes, but the pr they issued is to pump the price. $gild would never issue that.|scan results - 
2017-03-02: valeant: probably worthless, or risky but attractive now?  $abbv $abt $agn $endp $gild $myl $prgo $teva $vrx|rt AT_USER so $gild didnt buy anything with $xbi in the 40-50s .... waiting for lower pps .
2017-03-03: rt AT_USER $gild weekly. initial follow through higher from the inside-inside weeks $ibb |rt AT_USER tgif - yellen and the people's congress #fomc $tza $gild $spy $dia #futures --  |rt AT_USER tgif - 
2017-03-04: AT_USER $gild complain basically after other lower price entry, they can't easily reset list price w/o changing existing contracts.|gilead: oncology acquisition incoming  $glpg $incy $nvs $rhhby $gild
2017-03-05: rt AT_USER AT_USER i've seen $gild for $incy countless times but never $pfe for them. would complement xeljanz and other inflamm¡­|rt AT_USER $gild or $bmrn? |rt AT_USER $incy too big for $gild now, a
2017-03-06: 5 things for #pharma #marketers to know: mon., mar. 6 $gild #drugprices $googl #ai #cancer $sny $regn #fda $agn¡­ |AT_USER $gild keeps on delivering superb results from its pipeline. don't worry keep 
2017-03-07: rbc hints at potential m&amp;a for kite pharma $gild $kite $nvs  via AT_USER|$gild $gild |rt AT_USER fiercebiotech¡¯s 2016 rotten tomatoes:  $juno $nvs $arwr $gild $nwbo and more|trump tweets about a 
2017-03-08: AT_USER AT_USER AT_USER AT_USER what i in roi? $gild bought phrmset for $11b, but hep c drugs r&amp;d was just $500m.|$esrx fires back at $gild |rt AT_USER trending: in quick rebuttal, express scripts
Answer:+Fall